Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.70 |
| ▸ | TAAR1 | Q96RJ0 | 6/20 | 0.64 |
| ▸ | LPL | P06858 | 1/20 | 0.46 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.46 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18762839 | 0.89 | HRH3 (0.84) | HRH3TAAR1CHRNA7KCNH2AOC3 | |
| SCHEMBL3053110 | 0.86 | HRH3 (0.64) | HRH3TAAR1KCNH2 | |
| SCHEMBL3057063 | 0.85 | HRH3 (0.70) | HRH3TAAR1CHRNA7KCNH2AOC3 | |
| SCHEMBL3052389 | 0.82 | TAAR1 (0.63) | HRH3TAAR1CHRNA7AOC3 | |
| SCHEMBL15935950 | 0.82 | THRA (0.63) | HRH3TAAR1LPLLIPGKCNH2 | |
| SCHEMBL26456364 | 0.81 | HRH3 (0.64) | HRH3TAAR1CHRNA7 | |
| SCHEMBL142480 | 0.81 | LPL (0.62) | TAAR1LPLLIPG | |
| SCHEMBL15242107 | 0.81 | HRH3 (0.58) | HRH3TAAR1CHRNA7 | |
| SCHEMBL3440327 | 0.81 | HRH3 (0.57) | HRH3TAAR1CHRNA7KCNH2 | |
| SCHEMBL3046909 | 0.80 | HRH3 (0.70) | HRH3TAAR1CHRNA7KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8394979-B2 | Process for preparing cycloplatinated platinum complexes, platinum complexes prepared by this process and the use thereof | RHEINISCHE-WESTFALISCHE TECHNISCHE HOCHSCHULE AACHEN (DE) | 2013-03-12 | — | — | US | disclosed |
| US-20100267977-A1 | METHOD FOR PRODUCING CYCLOPLATINIZED PLATINUM COMPLEXES, PLATINUM COMPLEXES PRODUCED BY SAID METHOD, AND THE USE THEREOF | RHEINISCHE-WESTFALISCHE TECHNISCHE HOCHSCHULE AACHEN (DE) | 2010-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100267977-A1 | METHOD FOR PRODUCING CYCLOPLATINIZED PLATINUM COMPLEXES, PLATINUM COMPLEXES PRODUCED BY SAID METHOD, AND THE USE THEREOF | THPO, MCL1, PPOX | HRH3 3145/4885TAAR1 4519/4885LPL 4666/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.